Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Impact of multiple sclerosis relapses on progression diminishes with time.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
Cross-Immunoreactivity between Bacterial Aquaporin-Z and Human Aquaporin-4: Potential Relevance to Neuromyelitis Optica.
Antidepressant activity of fingolimod in mice.
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.
Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.
Early development of anti-natalizumab antibodies in MS patients.
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
Multiple sclerosis, solitary sclerosis or something else?
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.
Pages
« first
‹ previous
…
191
192
193
194
195
196
197
198
199
…
next ›
last »